DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 207 filers reported holding DENALI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $113,000 | +391.3% | 3,700 | +362.5% | 0.01% | +350.0% |
| Q2 2022 | $23,000 | +360.0% | 800 | +379.0% | 0.00% | – |
| Q1 2022 | $5,000 | -97.0% | 167 | -95.5% | 0.00% | -100.0% |
| Q4 2021 | $166,000 | +690.5% | 3,742 | +768.2% | 0.01% | +550.0% |
| Q3 2021 | $21,000 | -79.4% | 431 | -67.0% | 0.00% | -75.0% |
| Q2 2021 | $102,000 | -74.9% | 1,306 | -81.7% | 0.01% | -79.5% |
| Q1 2021 | $407,000 | +284.0% | 7,129 | +139.1% | 0.04% | +225.0% |
| Q3 2020 | $106,000 | +37.7% | 2,981 | -33.4% | 0.01% | +50.0% |
| Q4 2019 | $77,000 | – | 4,477 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |